Baudax Bio falls on $2 mln equity offering
** Pharmaceutical company's shares BXRX.O down 24% at
$0.90 premarket
** BXRX announces $2 mln equity offering
** Equity offering part of agreement with certain
institutional investors for issuance of 1.6 mln shares at
$1.215/shr urn:newsml:reuters.com:*:nGNX3zcZ5T
** Baudax Bio has 6.4 mln shares outstanding - Refinitiv
data
** Company's shares down 85% YTD, up to last close
(Reporting by Leroy Leo in Bengaluru)
((Leroy.Dsouza@thomsonreuters.com; Twitter: https://twitter.com/LeroyLeo7))
Recent news on Baudax Bio
See all newsBrief: Baudax Bio On Feb 22, Filed Voluntary Petition Under Chapter 11 Of U.S. Bankruptcy Code
Brief: Baudax Bio Says Substantial Doubt Exists About Ability To Continue As A Going Concern For Next Twelve Months
Baudax Bio Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Baudax Bio Says Phase 1/2a Clinical Study of TI-168 In Hemophilia A with FVIII Inhibitors Projected to Begin Q1 2024
Brief: Baudax Bio Inc - On October 5, 2023, Board Of Directors Of Company Appointed Natalie Mcandrew As Interim Chief Financial Officer